Molecular mechanisms of cardiomyocyte aging

Clinical Science

Volumn 121, Issue 8, 2011, Pages 315-329

  Anna, A ^a   Riordon, Daniel R ^a   Boheler, KennethR ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Apoptosis; Cardiomyocyte; Cardiovascular Disease.

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA ACTIN; ALPHA CARDIAC ACTIN; ALPHA SKELETAL ACTIN; ANGIOTENSIN 2 RECEPTOR; ATRIAL NATRIURETIC FACTOR; BETA ARRESTIN; BRAIN NATRIURETIC PEPTIDE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CXCL14 CHEMOKINE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLOOXYGENASE 2; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2; SODIUM CALCIUM EXCHANGE PROTEIN; SOMATOMEDIN C; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTOME; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOPHAGY; CARDIOVASCULAR DISEASE; CELL AGING; CELL DAMAGE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; CHROMOSOME 14; DISEASE COURSE; DNA FRAGMENTATION; DNA SYNTHESIS; DOWN REGULATION; ELECTRON TRANSPORT; EPIGENETICS; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GLUTATHIONE METABOLISM; HEART CONTRACTION; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HUMAN; HYPERTROPHY; LONGEVITY; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; UPREGULATION;

ANIMALS; APOPTOSIS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL AGING; CELL PROLIFERATION; CPG ISLANDS; EPIGENESIS, GENETIC; GENETIC VARIATION; HUMANS; HYPERTROPHY; MICE; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; OXYGEN CONSUMPTION; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 80052316167     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110115     Document Type: Review

References (151)

1. Lakatta, E. G. (1993) Cardiovascular regulatory mechanisms in advanced age. Physiol. Rev. 73, 413-467
2. Najjar, S. S., Scuteri, A. and Lakatta, E. G. (2005) Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 46, 454-462
3. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., Kissela, B. et al. (2008) Heart disease and stroke statistics -2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, E25-E146
4. Volkova, M., Garg, R., Dick, S. and Boheler, K. R. (2005) Aging-associated changes in cardiac gene expression. Cardiovasc. Res. 66, 194-204
5. Lakatta, E. G. (1999) Circulatory function in younger and older humans in health. In Principles of Geriatric Medicine and Gerontology (W. R. Hazzard, ed.), pp. 645-660, McGraw-Hill Companies, New York
6. Fleg, J. L., O'Connor, F., Gerstenblith, G., Becker, L. C., Clulow, J., Schulman, S. P. and Lakatta, E. G. (1995) Impact of age on the cardiovascular-response to dynamic upright exercise in healthy-men and women. J. Appl. Physiol. 78, 890-900
7. Chang, K. C., Peng, Y. I., Dai, S. H. and Tseng, Y. Z. (2000) Age-related changes in pumping mechanical behavior of rat ventricle in terms of systolic elastance and resistance. J. Gerontol. Series A Biol. Sci. Med. Sci. 55, B440-B447
8. Schwartz, J. B. and Zipes, D. P. (2007) Cardiovascular Disease in the Elderly. In Braunwald's Heart Disease: a Textbook of Cardiovascular Medicine (P. Libby, R. O. Bonow, D. L. Mann and D. P. Zipes, eds), pp. 1923-1953 Saunders Elsevier, Philadelphia
9. Hees, P. S., Fleg, J. L., Mirza, Z., Ahmed, S., Lakatta, E. G. and Shapiro, E. P. (2002) Left ventricular diastolic functional reserve declines with age despite preserved relaxation reserve. Circulation 106, 708-709
10. Olivetti, G., Melissari, M., Capasso, J. M. and Anversa, P. (1991) Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ. Res. 68, 1560-1568
11. Anversa, P., Hiler, B., Ricci, R., Guideri, G. and Olivetti, G. (1986) Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J. Am. Coll. Cardiol. 8, 1441-1448
12. Anversa, P., Palackal, T., Sonnenblick, E. H., Olivetti, G., Meggs, L. G. and Capasso, J. M. (1990) Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ. Res. 67, 871-885
13. Kajstura, J., Cigola, E., Malhotra, A., Li, P., Cheng, W., Meggs, L. G. and Anversa, P. (1997) Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J. Mol. Cell. Cardiol. 29, 859-870
14. Cigola, E., Kajstura, J., Li, B. S.,Meggs, L. G. and Anversa, P. (1997) Angiotensin II activates programmed myocyte cell death in vitro. Exp. Cell Res. 231, 363-371
15. Swynghedauw, B. (1999) Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79, 215-262
16. Barker, D. J. P., Osmond, C., Kajantie, E and Eriksson, J. G. (2009) Growth and chronic disease: findings in the Helsinki Birth Cohort. Ann. Hum. Biol. 36, 445-458
17. Petry, C. J. and Hales, C. N. (2000) Long-term effects on offspring of intrauterine exposure to deficits in nutrition. Hum. Reprod. Update 6, 578-586
18. Swynghedauw, B. (1986) Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol. Rev. 66, 710-771
19. Swynghedauw, B., Besse, S., Assayag, P., Carre, F., Chevalier, B., Charlemagne, D., Delcayre, C., Hardouin, S., Heymes, C. and Moalic, J. M. (1995) Molecular and cellular biology of the senescent hypertrophied and failing heart. Am. J. Cardiol. 76, D2-D7
20. Long, X., Boluyt, M. O., O'Neill, L., Zheng, J. S.,Wu, G., Nitta, Y. K., Crow, M. T. and Lakatta, E. G. (1999) Myocardial retinoid X receptor, thyroid hormone receptor, and myosin heavy chain gene expression in the rat during adult aging. J. Gerontol. A. Biol. Sci. Med. Sci. 54, B23-B27
21. Lompŕe, A. -M., Mercadier, J. J., Wisnewsky, C., Bouveret, P., Pantaloni, C., D'Albis, A. and Schwartz, K. (1981) Species and age-dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals. Dev. Biol. 84, 286-290
22. Mercadier, J. J., de la Bastie, D., Menasche, P., Van Cao, A. N., Bouveret, P., Lorente, P., Piwnica, A., Slama, R. and Schwartz, K. (1987) α-Myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: a quantitative study. J. Am. Coll. Cardiol. 9, 1024-1030
23. Boheler, K. R., Chassagne, C., Martin, X., Wisnewsky, C. and Schwartz, K. (1992) Cardiac expressions of α- and β-myosin heavy chains and sarcomeric α-actins are regulated through transcriptional mechanisms. J. Biol. Chem. 267, 12979-12985
24. Swynghedauw, B., Delcayre, C., Moalic, J. M., Lecarpentier, Y., Ray, A., Mercadier, J. J., Lompre, A. M., Aumont, M. C. and Schwartz, K. (1982) Isoenzymic changes in myosin and hypertrophy; adaptation during chronic mechanical overload. Eur. Heart J. 3 (Suppl. A), 75-82
25. Xu, Q., Dewey, S., Nguyen, S. and Gomes, A. V. (2010) Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes. J. Mol. Cell. Cardiol. 48, 899-909
26. Carrier, L., Boheler, K. R., Chassagne, C., de la Bastie, D., Wisnewsky, C., Lakatta, E. G. and Schwartz, K. (1992) Expression of the sarcomeric actin isogenes in the rat heart with development and senescence. Circ. Res. 70, 999-1005
27. Ilkovski, B., Clement, S., Sewry, C., North, K. N. and Cooper, S. T. (2005) Defining α-skeletal and α-cardiac actin expression in human heart and skeletal muscle explains the absence of cardiac involvement in ACTA1 nemaline myopathy. Neuromusc. Disord. 15, 829-835
28. 2+ -ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ. Res. 69, 1380-1388
29. Assayag, P., Charlemagne, D., deLeiris, J., Boucher, F., Valere, P. E., Lortet, S., Swynghedauw, B. and Besse, S. (1997) Senescent heart compared with pressure overload-induced hypertrophy. Hypertension 29, 15-21
30. Jiang, M. T., Moffat, M. P. and Narayanan, N. (1993) Age-related alterations in the phosphorylation of sarcoplasmic reticulum and myofibrillar proteins and diminished contractile response to isoproterenol in intact rat ventricle. Circ. Res. 72, 102-111
31. Cain, B. S., Meldrum, D. R., Joo, K. S., Wang, J. F., Meng, X. Z., Cleveland, J. C., Banerjee, A. and Harken, A. H. (1998) Human SERCA2a levels correlate inversely with age in senescent human myocardium. J. Am. Coll. Cardiol. 32, 458-467
32. 2+ -handling proteins and effects of isoproterenol. Am. J. Physiol. Heart Circ. Physiol. 277, H2083-H2090
33. 2+ exchange. J. App. Physiol. 95, 1994-2003
34. 2+ exchange in rat papillary muscle. J. Gerontol. Series A Biol. Sci. Med. Sci. 51, M251-M259
35. 2+ exchanger NCX1 gene promoter is sufficient to confer cardiac-specific expression. Mech. Dev. 109, 267-279
36. Lakatta, E. G. and Sollott, S. J. (2002) Perspectives on mammalian cardiovascular aging: humans to molecules. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 132, 699-721
37. 2+ transport proteins in a rat heart. Mol. Cell. Biochem. 301, 219-226
38. Anisimov, S. V. and Boheler, K. R. (2003) Agingassociated changes in cardiac gene expression: large scale transcriptome analysis. Adv. Gerontol. 11, 67-75
39. Heymes, C., Silvestre, J. S., Llorens-Cortes, C., Chevalier, B., Marotte, F., Levy, B. I., Swynghedauw, B. and Samuel, J. L. (1998) Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes. Endocrinology 139, 2579-2587
40. Del Ry, S., Maltinti, M., Giannessi, D., Cavallini, G and Bergamini, E. (2008) Age-related changes in endothelin-1 receptor subtypes in rat heart. Exp. Aging Res. 34, 251-266
41. Hardouin, S., Mansier, P., Bertin, B., Dakhly, T., Swynghedauw, B. and Moalic, J. M. (1997) β-Adrenergic and muscarinic receptor expression are regulated in opposite ways during senescence in rat left ventricle. J. Mol. Cell. Cardiol. 29, 309-319
42. Hardouin, S., Bourgeois, F., Besse, S., Machida, C. A., Swynghedauw, B. and Moalic, J. M. (1993) Decreased Accumulation of β1-adrenergic receptor, G-α-S and total myosin heavy-chain messenger-rnas in the left-ventricle of senescent rat-heart. Mech. Ageing Dev. 71, 169-188
43. Dobson, J. G., Fray, J., Leonard, J. L. and Pratt, R. E. (2003) Molecular mechanisms of reduced β-adrenergic signaling in the aged heart as revealed by genomic profiling. Physiol. Genomics 15, 142-147
44. Annoni, G., Luvara, G., Arosio, B., Gagliano, N., Fiordaliso, F., Santambrogio, D., Jeremic, G., Mircoli, L., Latini, R., Vergani, C. and Masson, S. (1998) Age-dependent expression of fibrosis-related genes and collagen deposition in the rat myocardium. Mech. Ageing Dev. 101, 57-72
45. Thomas, D. P., Zimmerman, S. D., Hansen, T. R., Martin, D. T. and McCormick, R. J. (2000) Collagen gene expression in rat left ventricle: interactive effect of age and exercise training. J. Appl. Physiol. 89, 1462-1468
46. Younes, A., Boluyt, M. O., O'Neill, L., Meredith, A. L., Crow, M. T. and Lakatta, E. G. (1995) Age-associated increase in rat ventricular ANP gene expression correlates with cardiac hypertrophy. Am. J. Physiol. 269, H1003-H1008
47. Charloux, A., Brandenberger, G., Piquard, F. and Geny, B. (2008) Dysregulation of pulsatility in aging IV. Pulsatile signaling and cardiovascular aging: functions and regulation of natriuretic peptide signaling. Ageing Res. Rev. 7, 151-163
48. Wallace, D. C. (2001) A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found. Symp. 235, 247-263
49. Lesnefsky, E. J., Moghaddas, S., Tandler, B., Kerner, J. and Hoppe,l, C. L. (2001) Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J. Mol. Cell. Cardiol. 33, 1065-1089
50. Park, S. K. and Prolla, T. A. (2005) Lessons learned from gene expression profile studies of aging and caloric restriction. Ageing Res. Rev. 4, 55-65
51. Bodyak, N., Kang, P. M.,Hiromura, M., Sulijoadikusumo, I., Horikoshi, N., Khrapko, K. and Usheva, A. (2002) Gene expression profiling of the aging mouse cardiac myocytes. Nucleic Acids Res. 30, 3788-3794
52. Lee, C. K., Allison, D. B., Brand, J., Weindruch, R. and Prolla, T. A. (2002) Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc. Natl. Acad. Sci. U.S.A. 99, 14988-14993
53. Zahn, J. M., Poosala, S., Owen, A. B., Ingram, D. K., Lustig, A., Carter, A., Weeraratna, A. T., Taub, D. D., Gorospe, M., Mazan-Mamczarz, K. et al. (2007) AGEMAP: a gene expression database for aging in mice. PLoS Genet. 3, e201
54. Linford, N. J., Beyer, R. P., Gollahon, K., Krajcik, R. A., Malloy, V. L., Demas, V., Burmer, G. C. and Rabinovitch, P. S. (2007) Transcriptional response to aging and caloric restriction in heart and adipose tissue. Aging Cell 6, 673-688
55. Brink, T. C., Demetrius, L., Lehrach, H. and Adjaye, J. (2009) Age-related transcriptional changes in gene expression in different organs of mice support the metabolic stability theory of aging. Biogerontology 10, 549-564
56. Park, S. K., Page, G. P., Kim, K., Allison, D. B., Meydani, M., Weindruch, R. and Prolla, T. A. (2008) α- and γ -Tocopherol prevent age-related transcriptional alterations in the heart and brain of mice. J. Nutr. 138, 1010-1018
57. Park, S. K., Kim, K., Page, G. P., Allison, D. B., Weindruch, R and Prolla, T. A. (2009) Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants. Aging Cell 8, 484-495
58. Wolf, N. S. and Austad, S. (2010) Introduction: lifespans and pathologies present at death in laboratory animals. In The Comparative Biology of Aging (N. S. Wolf, ed.), pp. 1-26, Springer, New York
59. Boheler, K. R., Volkova, M., Morrell, C., Garg, R., Zhu, Y., Margulies, K., Seymour, A. M. and Lakatta, E. G. (2003) Sex- and age-dependent human transcriptome variability: Implications for chronic heart failure. Proc. Natl. Acad. Sci. U.S.A. 100, 2754-2759
60. Brink, T. C., Regenbrecht, C., Demetrius, L., Lehrach, H. and Adjaye, J. (2009) Activation of the immune response is a key feature of aging in mice. Biogerontology 10, 721-734
61. Park, S. K. and Prolla, T. A. (2005) Gene expression profiling studies of aging in cardiac and skeletal muscles. Cardiovasc. Res. 66, 205-212
62. Jonker, S. S., Zhang, L. B., Louey, S., Giraud, G. D., Thornburg, K. L. and Faber, J. J. (2007) Myocyte enlargement, differentiation, and proliferation kinetics in the fetal sheep heart. J. Appl. Physiol. 102, 1130-1142
63. Jonker, S. S., Faber, J. J., Anderson, D. F., Thornburg, K. L., Louey, S. and Giraud, G. D. (2007) Sequential growth of fetal sheep cardiac myocytes in response to simultaneous arterial and venous hypertension. Am. J. Physiol. Regulat. Integr. Comp. Physiol. 292, R913-R919
64. Walsh, S., Ponten, A., Fleischmann, B. K. and Jovinge, S. (2010) Cardiomyocyte cell cycle control and growth estimation in vivo: an analysis based on cardiomyocyte nuclei. Cardiovasc. Res. 86, 365-373
65. Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H. et al. (2009) Evidence for cardiomyocyte renewal in humans. Science 324, 98-102
66. Rubart, M. and Field, L. J. (2006) Cell-based approaches for cardiac repair. Ann. N. Y. Acad. Sci. 1080, 34-48
67. Rubart, M. and Field, L. J. (2006) Cardiac regeneration: repopulating the heart. Annu. Rev. Physiol. 68, 29-49
68. Yamanaka, S., Zahanich, I., Wersto, R. P. and Boheler, K. R. (2008) Enhanced proliferation of monolayer cultures of embryonic stem (ES) cell-derived cardiomyocytes following acute loss of retinoblastoma. PLoS ONE 3, e3896
69. Biehl, J. K., Yamanaka, S., Desai, T. A., Boheler, K. R. and Russell, B. (2009) Proliferation of mouse embryonic stem cell progeny and the spontaneous contractile activity of cardiomyocytes are affected by microtopography. Dev. Dyn. 238, 1964-1973
70. MacLellan, W. R., Garcia, A., Oh, H., Frenkel, P., Jordan, M. C., Roos, K. P. and Schneider, M. D. (2005) Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol. Cell. Biol. 25, 2486-2497
71. Soonpaa, M. H., Koh, G. Y., Pajak, L., Jing, S., Wang, H., Franklin, M. T., Kim, K. K. and Field, L. J. (1997) Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J. Clin. Invest. 99, 2644-2654
72. Pasumarthi, K. B. S., Nakajima, H., Nakajima, H. O., Soonpaa, M. H. and Field, L. J. (2005) Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ. Res. 96, 110-118
73. Liao, H. S., Kang, P. M., Nagashima, H., Yamasaki, N., Usheva, A., Ding, B., Lorell, B. H. and Izumo, S. (2001) Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes. Circ. Res. 88, 443-450
74. Perino, M. G., Yamanaka, S., Li, J. L., Wobus, A. M. and Boheler, K. R. (2008) Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis. J. Mol. Cell. Cardiol. 45, 475-494
75. Hill, J. A. and Olson, E. N. (2008) Mechanisms of disease: cardiac plasticity. N. Eng. J. Med. 358, 1370-1380
76. Heineke, J. and Molkentin, J. D. (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7, 589-600
77. Muslin, A. J. (2008) MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin. Sci. 115, 203-218
78. Wei, J. Q., Shehadeh, L. A., Mitrani, J. M., Pessanha, M., Slepak, T. I., Webster, K. A. and Bishopric, N. H. (2008) Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 118, 934-946
79. Wilkins, B. J., Dai, Y. S., Bueno, O. F., Parsons, S. A., Xu, J., Plank, D. M., Jones, F., Kimball, T. R. and Molkentin, J. D. (2004) Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94, 110-118
80. Diedrichs, H., Chi, M., Boelck, B., Brixius, C., Mehlhorn, U. and Schwinger, R. H. G. (2004) Activation of the calcineurin/NFAT signalling cascade in human hypertrophied myocardium. Eur. Heart J. 25, 180-180
81. Prasad, A. M. and Inesi, G. (2011) Silencing calcineurin A subunit reduces SERCA2 expression in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 300, H173-H180
82. Wang, L. J., Gout, I. and Proud, C. G. (2001) Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways: MEK-dependent activation of S6K2 in cardiomyocytes. J. Biol. Chem. 276, 32670-32677
83. Goodfellow, S. J., Innes, F., Derblay, L. E., MacLellan, W. R., Scott, P. H. and White, R. J. (2006) Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J. 25, 1522-1533
84. Wang, L. J. and Proud, C. G. (2002) Ras/Erk signaling is essential for activation of protein synthesis by Gq protein receptor agonists in adult cardiomyocytes. Circ. Res. 91, 821-829
85. Lorenz, K., Schmitt, J. P., Vidal, M. and Lohse, M. J. (2009) Cardiac hypertrophy: Targeting Raf/MEK/ERK1/2-signaling. Int. J. Biochem. Cell Biol. 41, 2351-2355
86. Chimenti, C., Kajstura, J., Torella, D., Urbanek, K., Heleniak, H., Colussi, C., Di Meglio, F., Nadal-Ginard, B., Frustaci, A., Leri, A. et al. (2003) Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res. 93, 604-613
87. Urbanek, K., Quaini, F., Tasca, G., Torella, D., Castaldo, C., Nadal-Ginard, B., Leri, A., Kajstura, J., Quaini, E. and Anversa, P. (2003) Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 19, 10440-10445
88. Fossel, M. (2000) Cell senescence in human aging: a review of the theory. In Vivo 14, 29-34
89. Rodier, F., Kim, S. H., Nijjar, T., Yaswen, P. and Campisi, J. (2005) Cancer and aging: the importance of telomeres in genome maintenance. Int. J. Biochem. Cell Biol. 37, 977-990
90. Itahana, K., Campisi, J. and Dimri, G. P. (2004) Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5, 1-10
91. Campisi, J. (2003) Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp. Gerontol. 38, 5-11
92. Leri, A., Malhotra, A., Liew, C. C., Kajstura, J. and Anversa, P. (2000) Telomerase activity in rat cardiac myocytes is age and gender dependent. J. Mol. Cell. Cardiol. 32, 385-390
93. Rota, M., Hosoda, T., De Angelis, A., Arcarese, M. L., Esposito, G., Rizzi, R., Tillmanns, J., Tugal, D., Musso, E., Rimoldi, O. et al. (2007) The young mouse heart is composed of myocytes heterogeneous in age and function. Circ. Res. 101, 387-399
94. Ball, A. J. and Levine, F. (2005) Telomere-independent cellular senescence in human fetal cardiomyocytes. Aging Cell 4, 21-30
95. Leri, A., Franco, S., Zacheo, A., Barlucchi, L., Chimenti, S., Limana, F., Nadal-Ginard, B., Kajstura, J., Anversa, P and Blasco, M. A. (2003) Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 22, 131-139
96. Oh, H., Taffet, G. E., Youker, K. A., Entman, M. L., Overbeek, P. A., Michael, L. H. and Schneider, M. D. (2001) Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl. Acad. Sci. U.S.A. 98, 10308-10313
97. Wong, L. S. M., de Boer, R. A., Samani, N. J., van Veldhuisen, D. J. and van der Harst, P. D. (2008) Telomere biology in heart failure. Eur. J. Heart Failure 10, 1049-1056
98. Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., DiLoreto, C., Beltrami, C. A., Krajewski, S. et al. (1997) Apoptosis in the failing human heart. N. Eng. J. Med. 336, 1131-1141
99. Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., DiLoreto, C., Beltrami, C. A., Krajewski, S. et al. (1996) Programmed myocyte cell death affects the failing human heart. Circulation 94, 908-908
100. Desagher, S. and Martinou, J. C. (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10, 369-377
101. Haunstetter, A. and Izumo, S. (1998) Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ. Res. 82, 1111-1129
102. Li, H. L., Zhu, H., Xu, C. J. and Yuan, J. Y. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501
103. Centurione, L., Antonucci, A., Miscia, S., Grilli, A., Rapino, M., Grifone, G., Di Giacomo, V., Di Giulio, C., Falconi, M. and Cataldi, A. (2002) Age-related death-survival balance in myocardium: an immunohistochemical and biochemical study. Mech. Ageing Dev. 123, 341-350
104. Kubota, T., Miyagishima, M., Frye, C. S., Alber, S. M., Bounoutas, G. S., Kadokami, T., Watkins, S. C., McTiernan, C. F. and Feldman, A. M. (2001) Overexpression of tumor necrosis factor-α activates both anti- and pro-apoptotic pathways in the myocardium. J. Mol. Cell. Cardiol. 33, 1331-1344
105. Haudek, S. B., Taffet, G. E., Schneider, M. D. and Mann, D. L. (2007) TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J. Clin. Invest. 117, 2692-2701
106. Vasan, R. S., Sullivan, L. M., D'Agostino, R. B., Roubenoff, R., Harris, T., Sawyer, D. B., Levy, D. and Wilson, P. W. F. (2003) Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann. Int. Med. 139, 642-648
107. Welch, S., Plank, D., Witt, S., Glascock, B., Schaefer, E., Chimenti, S., Andreoli, A. M., Limana, F., Leri, A., Kajstura, et al. (2002) Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulinoverexpressing transgenic mice. Circ. Res. 90, 641-648
108. Christensen, K., Johnson, T. E. and Vaupel, J. W. (2006) The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 7, 436-448
109. Rabinovitch, P. S., Dai, D. F., Liu, Y., Chin, M. T. and Szeto, H. H. (2010) Mitochondrial ROS and mtDNA mutations: a central role in cardiac health and aging? Environ. Mol. Mutagen. 51, 694-694
110. Dai, D. F. and Rabinovitch, P. S. (2009) Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc. Med. 19, 213-220
111. Juhaszova, M., Wang, S., Zorov, D. B., Nuss, H. B., Gleichmann, M., Mattson, M. P. and Sollott, S. J. (2008) The identity and regulation of the mitochondrial permeability transition pore: where the known meets the unknown. Ann. N. Y. Acad. Sci. 1123, 197-212
112. Wallace, D. C. (2010) Mitochondrial DNA mutations in disease and aging. Environ. Mol. Mutagen. 51, 440-450
113. Zorov, D. B., Juhaszova, M. and Sollott, S. J. (2006) Mitochondrial ROS-induced ROS-release: an update and review. Biochim. Biophys. Acta 1757, 52-53
114. Schoeler, S., Szibor, R., Gellerich, F. N., Wartmann, T., Mawrin, C., Dietzmann, K. and Kirches, E. (2005) Mitochondrial DNA deletions sensitize cells to apoptosis at low heteroplasmy levels. Biochem. Biophys. Res. Commun. 332, 43-49
115. Fosslien, E. (2003) Mitochondrial medicine: cardiomyopathy caused by defective oxidative phosphorylation. Ann. Clin. Lab. Sci. 33, 371-395
116. Chinnery, P. F., Samuels, D. C., Elson, J. and Turnbull, D. M. (2002) Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? Lancet 360, 1323-1325
117. Elson, J. L., Samuels, D. C., Turnbull, D. M. and Chinnery, P. F. (2001) Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am. J. Hum. Genet. 68, 802-806
118. Juhaszova, M., Zorov, D. B., Kim, S. H., Pepe, S., Fu, Q., Fishbein, K. W., Ziman, B. D., Wang, S., Ytrehus, K., Antos, C. L. et al. (2004) Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113, 1535-1549
119. Juhaszova, M., Rabuel, C., Zorov, D. B., Lakatta, E. G. and Sollott, S. J. (2005) Protection in the aged heart: preventing the heart-break of old age? Cardiovasc. Res. 66, 233-244
120. Kostin, S., Pool, L., Elsasser, A., Hein, S., Drexler, H. C. A., Arnon, E., Hayakawa, Y., Zimmermann, R., Bauer, E., Klovekorn, W. P. and Schaper, J. (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ. Res. 92, 715-724
121. Bae, S., Yalamarti, B. and Kang, P. M. (2008) Role of caspase-independent apoptosis in cardiovascular diseases. Front. Biosci. 13, 2495-2503
122. Joza, N., Oudit, G. Y., Brown, D., Benit, P., Kassiri, Z., Vahsen, N., Benoit, L., Patel, M. M., Nowikovsky, K., Vassault, A., Backx, P. H. et al. (2005) Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol. Cell. Biol. 25, 10261-10272
123. Xiao, C. Y., Chen, M., Zsengeller, Z., Li, H. S., Kiss, L., Kollai, M. and Szabo, C. (2005) Poly(ADP-ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure. J. Pharmacol. Exp. Ther. 312, 891-898
124. Xiao, C. Y., Chen, M., Zsengeller, Z. and Szabo, C. (2004) Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor. J. Pharmacol. Exp. Ther. 310, 498-504
125. Klein, J. A., Longo-Guess, C. M., Rossmann, M. P., Seburn, K. L., Hurd, R. E., Frankel,W. N., Bronson, R. T. and Ackerman, S. L. (2002) The harlequin mouse mutation down-regulates apoptosis-inducing factor. Nature 419, 367-374
126. van Empel, V. P. M., Bertrand, A. T., van der Nagel, R., Kostin, S., Doevendans, P. A., Crijns, H. J., de Wit, E., Sluiter, W., Ackerman, S. L. and DeWindt, L. J. (2005) Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ. Res. 96, E92-E101
127. Crabbe, R. A. and Hill, K. A. (2010) Heart tissue of harlequin (hq)/Big Blue (R) mice has elevated reactive oxygen species without significant impact on the frequency and nature of point mutations in nuclear DNA. Mutat. Res. 691, 64-71
128. Dai, D. F., Santana, L. F., Vermulst, M., Tomazela, D. M., Emond, M. J., MacCoss, M. J., Gollahon, K., Martin, G. M., Loeb, L. A., Ladiges, W. C. and Rabinovitch, P. S. (2009) Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 119, 2789-2797
129. Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N. et al. (2005) Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909-1911
130. Schriner, S. E. and Linford, N. J. (2006) Extension of mouse lifespan by overexpression of catalase. Age 28, 209-218
131. Dai, D. F., Linford, N. J., Santana, L. F., Treuting, P., Ladiges, W. and Rabinovitch, P. S. (2006) Mice overexpressing mitochondrial-targeted catalase are protected against cardiac aging. Eur. Heart J. 27, 875-876
132. Avogaro, A., de Kreutzenberg, S. V. and Fadini, G. P. (2010) Insulin signaling and life span. Pflugers Arch. 459, 301-314
133. McMullen, J. R., Amirahmadi, F., Woodcock, E. A., Schinke-Braun, M., Bouwman, R. D., Hewitt, K. A., Mollica, J. P., Zhang, L., Zhang, Y. Y., Shioi, T. et al. (2007) Protective effects of exercise and phosphoinositide 3-kinase (p110α) signaling in dilated and hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. U.S.A. 104, 612-617
134. Alcendor, R. R., Gao, S. M., Zhai, P. Y., Zablocki, D., Holle, E., Yu, X. Z., Tian, B., Wagner, T., Vatner, S. F. and Sadoshima, J. (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100, 1512-1521
135. Alcendor, R. R., Kirshenbaum, L. A., Imai, S., Vatner, S. F. and Sadoshima, J. (2004) Silent information regulator 2α, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ. Res. 95, 971-980
136. Vakhrusheva, O., Smolka, C., Gajawada, P., Kostin, S., Boettger, T., Kubin, T., Braun, T. and Bober, E. (2008) Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 102, 703-710
137. Goll, M. G. and Bestor, T. H. (2005) Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74, 481-514
138. Thompson, R. F., Atzmon, G., Gheorghe, C., Liang, H. Q., Lowes, C., Greally, J. M. and Barzilai, N. (2010) Tissue-specific dysregulation of DNA methylation in aging. Aging Cell. 9, 506-518
139. Schones, D. E. and Zhao, K. (2008) Genome-wide approaches to studying chromatin modifications. Nat. Rev. Genet. 9, 179-191
140. Chu, M. W., Siegmund, K. D., Eckstam, C. L., Kim, J. Y., Yang, A. S., Kanel, G. C., Tavare, S. and Shibata, D. (2007) Lack of increases in methylation at three CpG-rich genomic loci in non-mitotic adult tissues during aging. BMC Med. Genet. 8, 50
141. Dzitoyeva, S., Imbesi, M., Ng, L. W. and Manev, H. (2009) 5-Lipoxygenase DNA methylation and mrna content in the brain and heart of young and old mice. Neural Plast. 2009, 209596
142. Li, Y. P., Liu, Y., Strickland, F. M. and Richardson, B. (2010) Age-dependent decreases in DNA methyltransferase levels and low transmethylation micronutrient levels synergize to promote overexpression of genes implicated in autoimmunity and acute coronary syndromes. Exp. Gerontol. 45, 312-322
143. Post, W. S., Goldschmidt-Clermont, P. J.,Wilhide, C. C., Heldman, A. W., Sussman, M. S., Ouyang, P., Milliken, E. E. and Issa, J. P. (1999) Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43, 985-991
144. Bushati, N. and Cohen, S. M. (2007) microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 173-205
145. Liu, N. and Olson, E. N. (2010) MicroRNA regulatory networks in cardiovascular development. Dev. Cell. 18, 510-525
146. Small, E. M. and Olson, E. N. (2011) Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336-342
147. Rao, P. K., Toyama, Y., Chiang, H. R., Gupta, S., Bauer, M., Medvid, R., Reinhardt, F., Liao, R., Krieger, M., Jaenisch, R. et al. (2009) Loss of cardiac microRNAmediated regulation leads to dilated cardiomyopathy and heart failure. Circ. Res. 105, 585-594
148. Martins, P. A. D. C., Bourajjaj, M., Gladka, M., Kortland, M., van Oort, R. J., Pinto, Y. M., Molkentin, J. D. and De Windt, L. J. (2008) Conditional Dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118, 1567-1576
149. Lakatta, E. G. (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises, Part III: cellular and molecular clues to heart and arterial aging. Circulation 107, 490-497
150. Yan, S. F., Ramasamy, R. and Schmidt, A. M. (2009) The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease. Expert Rev. Mol. Med. 11, e9
151. Thomas, M. C., Baynes, J.W., Thorpe, S. R. and Cooper, M. E. (2005) The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr. Drug Targets 6, 453-474